Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU4-62P (RNA, U4 small nuclear 62, pseudogene) is annotated as a pseudogene corresponding to the U4 small nuclear RNA, a component found within the spliceosome complex in eukaryotic cells[1]. Unlike its functional counterparts (such as RNU4-2), RNU4-62P is not protein-coding and is generally believed to lack biological function; there are no reported associations with diseases or therapeutic targeting for this pseudogene, nor any drug interactions or biomarker utility. RNU4-62P should not be confused with the active RNU4-2 gene, which encodes a snRNA essential for pre-mRNA splicing and is implicated in neurodevelopmental disorders. As a pseudogene, RNU4-62P is not considered a functional molecular target[1]. Note: - There is confusion risk: RNU4-2 (not RNU4-62P) is the gene implicated in spliceosome biology and neurodevelopmental disorders[2][3][5]. - RNU4-62P is most likely not a true target; all therapeutic, pathological, and mechanistic findings in current research relate to RNU4-2, not the pseudogene[1][3][5]. - If the query intended to reference the functional U4 snRNA or RNU4-2, supplementary clarification would be needed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4 small nuclear 62, pseudogene (RNU4-62P).